Gothenburg, Sweden

Jan Thurin

This inventor holds 1 USPTO granted patent. Top assignee: Sloan-Kettering Institute for Cancer Research. Active years: 1987.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Jan Thurin. Retrieved from https://idiyas.com/inventor/jan-thurin-tadznt8q

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 8.0

ph-index = 1

Forward Citations = 10(Granted Patents)


Company Filing History:


Years Active: 1987

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Jan Thurin - Innovator in Blood Typing Technology

Introduction

Jan Thurin is a notable inventor based in Gothenburg, Sweden. She has made significant contributions to the field of medical diagnostics, particularly in blood typing technology. Her work focuses on the development of monoclonal antibodies that are crucial for detecting specific blood group antigens.

Latest Patents

Jan Thurin holds a patent for "Monoclonal antibodies for detection of an H (O) blood group antigen." This patent discloses monoclonal antibodies that recognize the difucosyl-type-2-H antigen on human cells. The antibodies are instrumental in blood typing and diagnosing blood disorders and malignancies associated with the loss or gain of the H antigen.

Career Highlights

Thurin is affiliated with the Sloan-Kettering Institute for Cancer Research, where she continues her research and development efforts. Her innovative work has the potential to enhance the accuracy of blood typing and improve patient outcomes in various medical conditions.

Collaborations

Jan Thurin has collaborated with esteemed colleagues, including Kenneth O. Lloyd and Lloyd J. Old. These partnerships have furthered her research and contributed to advancements in the field of cancer research and diagnostics.

Conclusion

Jan Thurin's contributions to the field of blood typing through her innovative patent demonstrate her commitment to improving medical diagnostics. Her work is vital for enhancing the understanding and treatment of blood-related disorders.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…